GlassScriptPhysician profile
Jeffrey H Lumerman
NPI 1083677272
$2,212.98
in general payments reported to CMS, 2019-2025
26 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $634 · 2020: $530 · 2021: $684 · 2022: $138 · 2023: $21.21 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $226.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $439.28 | 2019-2020 | |
| Allergan, INC. | $344.81 | 2020-2021 | |
| Neotract INC. | $307.32 | 2019 | |
| Coloplast Corp | $249.56 | 2019-2025 | Speedicath |
| Endo Pharmaceuticals INC. | $110.23 | 2020-2022 | |
| Pfizer INC. | $87.94 | 2020-2021 | |
| Civco Medical Instruments | $82.72 | 2025 | |
| Blue Earth Diagnostics | $64.55 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $53.98 | 2021-2022 | |
| Janssen Biotech, INC. | $49.58 | 2021-2022 | |
| Astellas Pharma US INC | $48.53 | 2021-2022 | |
| Urovant Sciences INC | $44.32 | 2021 | |
| Progenics Pharmaceuticals, INC. | $43.15 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $42.72 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.52 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $39.10 | 2025 | Itind System |
| Urogen Pharma, INC. | $30.51 | 2022 | |
| Antares Pharma, INC. | $24.77 | 2021 | |
| Merck Sharp & Dohme LLC | $23.88 | 2020 | |
| Baudax Bio INC. | $22.19 | 2020 | |
| Hollister Incorporated | $20.36 | 2022 | |
| Dentsply Ih INC. | $18.11 | 2021 | |
| Axonics, INC. | $13.93 | 2021 | |
| Glaxosmithkline, LLC. | $11.92 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lumerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.